Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 25, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning.

Ērika Bitiņa-Barlote1,2, Dmitrijs Bļizņuks3, Sanda Siliņa4

  • 1Institute of Oncology and Molecular Genetics, Riga Stradins University, LV-1002 Riga, Latvia.

Diagnostics (Basel, Switzerland)
|February 26, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

Prostate cancer and prostatic diseases·2026
Same author

Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.

European journal of human genetics : EJHG·2026
Same author

Urinary Outcomes Following a Novel Reconstructive Pelvic Organ Prolapse Surgery: Randomized Controlled Trial.

Medicina (Kaunas, Lithuania)·2026
Same author

Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial.

The Lancet. Oncology·2026
Same author

Baseline Gut Microbiome and Metabolite Profiles Associate with Treatment Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Diagnostics (Basel, Switzerland)·2026
Same author

Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study.

European journal of human genetics : EJHG·2026
This summary is machine-generated.

This study shows that combining microRNA (miRNA) data with routine clinical information improves non-invasive bladder cancer diagnosis. Machine learning models integrating these datasets enhance accuracy, offering a promising diagnostic approach.

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Diagnostics

Background:

  • Accurate and timely bladder cancer diagnosis remains a clinical challenge.
  • Conventional methods lack desired accuracy, sensitivity, and are invasive.
  • Machine learning offers potential for improved diagnostic accuracy.

Purpose of the Study:

  • To apply machine learning for enhanced bladder cancer diagnostics.
  • To integrate miRNA expression, lab results, and clinical data.
  • To improve non-invasive diagnostic accuracy.

Main Methods:

  • Utilized liquid biopsy for urinary exosome miRNA analysis.
  • Collected routine clinical, demographic, and patient test data.
  • Applied Random Forest, SVM, and XGBoost machine learning models.
Keywords:
artificial intelligencebiofluidsbiomarkerbladder cancerliquid biopsymachine learningmiRNAsmulti-modal dataurine exosomes

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.6K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

10.9K

Related Experiment Videos

Last Updated: May 25, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.6K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

10.9K

Main Results:

  • SVM model achieved an ROC of 0.75 with miRNA data alone.
  • Clinical/demographic data yielded an ROC of 0.80.
  • Combined data improved performance with an F1 score of 0.79 and ROC of 0.85.
  • Identified erythrocytes in urine, age, and specific miRNAs as key predictors.

Conclusions:

  • A multi-modal approach significantly enhances bladder cancer diagnostic accuracy.
  • This integrated strategy offers a promising non-invasive diagnostic method.
  • Machine learning effectively combines diverse datasets for improved clinical utility.